Massachusetts Financial Services’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$685K Sell
27,354
-729
-3% -$17.2K ﹤0.01% 873
2025
Q4
$739K Sell
28,083
-932
-3% -$20.3K ﹤0.01% 847
2025
Q3
$496K Buy
29,015
+1,906
+7% +$27.3K ﹤0.01% 830
2025
Q2
$340K Buy
27,109
+334
+1% +$3.98K ﹤0.01% 858
2025
Q1
$319K Sell
26,775
-610
-2% -$8.32K ﹤0.01% 863
2024
Q4
$401K Sell
27,385
-52,471
-66% -$734K ﹤0.01% 849
2024
Q3
$1M Sell
79,856
-1,933
-2% -$21K ﹤0.01% 797
2024
Q2
$696K Buy
+81,789
New +$728K ﹤0.01% 814

Other funds holding ZYME

Massachusetts Financial Services's ZYME Position: Q1 2026 in Review

Massachusetts Financial Services reduced its Zymeworks (ZYME) stake by 2.6% in Q1 2026, selling an estimated $17.2K and leaving 27,354 shares worth $685K. The position accounts for ﹤0.01% of the portfolio, ranked #873.

Massachusetts Financial Services first reported a position in ZYME in Q2 2024 and has held it in 8 quarters since. The position peaked at $1M in Q3 2024. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Massachusetts Financial Services held 27,354 shares of Zymeworks worth $685K as of Q1 2026.
  • Massachusetts Financial Services sold 729 Zymeworks shares in Q1 2026, an estimated $17.2K.
  • Zymeworks made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q1 2026, its #873 holding.
  • Massachusetts Financial Services first reported a position in Zymeworks in Q2 2024 and has held it in 8 quarters since.
  • Massachusetts Financial Services's Zymeworks position peaked at $1M in Q3 2024.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.